MFGE8 antibody
Quick Overview for MFGE8 antibody (ABIN7865692)
Target
See all MFGE8 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- anti-MFG-E8/ Lactadherin/p47 mouse monoclonal, MFG-06, purified
-
Purification
- affinity chromatography
-
Immunogen
- milk fat globule membrane preparation derived from human breast cancer cell line PMC42.
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
-
ICC/IF_dilution: 1:100-1:200 (0.5-1.0 μg/mL)
FACS_dilution: 0.5-1.0 μg/million cells in 0.1 ml
IHC-paraffin_dilution: 1:50-1:100 (1-2 μg/mL, microwave treatment in 10 mM citrate buffer pH 6.0 recommended)
WB_dilution: 1:50-1:100 (1-2 μg/mL)
IHC-frozen_dilution: 1:50-1:100 (1-2 μg/mL)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 100 μg/mL
-
Buffer
- PBS with 0.02 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- store at 2 - 8 °C
-
-
- MFGE8 (Milk Fat Globule-EGF Factor 8 Protein (MFGE8))
-
Alternative Name
- MFG-E8/ Lactadherin/p47
-
Background
- MFG-06 reacts with a glycoprotein of 40-45 kDa, known as Milk fat globule-EGF factor 8 protein (MFG-E8), lactadherin, p47 or milk fat globule 1 antigen. It is present on normal epithelial cells in various organs and considered a differentiation marker in carcinomas. It contains one EGF-like domain and 2 F5/8 type C domains. Functioning as a specific ligand for Integrin β5 and Integrin β3, MFG-E8 is thought to be involved in gamete interactions and cell attachment, possibly playing a role in fertilization and apoptosis. Additionally, MFG-E8 binds to rotavirus and inhibits its replication, thereby protecting the cell from viral infection. Overexpression of MFG-E8 is associated with breast cancer, suggesting that MFG-E8 may be related to tumorigenesis or progression. Among testicular carcinomas, seminomas are negative. Positive control: Normal breast or breast carcinoma.
-
Pathways
- SARS-CoV-2 Protein Interactome
Target
-